The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effect of a Single High Dose of Vitamin D 3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial
Open accessAbstract
Importance: The efficacy of vitamin D3 supplementation in coronavirus disease 2019 (COVID-19) remains unclear. Objective: To investigate the effect of a single high dose of vitamin D3 on hospital length of stay in patients with COVID-19. Design, Setting, and Participants: This was a multicenter, double-blind, randomized, placebo-controlled trial conducted in 2 sites in Sao Paulo, Brazil. The study included 240 hospitalized patients with COVID-19 who were moderately to severely ill at the time of enrollment from June 2, 2020, to August 27, 2020. The final follow-up was on October 7, 2020. Interventions: Patients were randomly assigned to receive a single oral dose of 200 000 IU of vitamin D3 (n = 120) or placebo (n = 120). Main Outcomes and Measures: The primary outcome was length of stay, defined as the time from the date of randomization to hospital discharge. Prespecified secondary outcomes included mortality during hospitalization; the number of patients admitted to the intensive care unit; the number of patients who required mechanical ventilation and the duration of mechanical ventilation; and serum levels of 25-hydroxyvitamin D, total calcium, creatinine, and C-reactive protein. Results: Of 240 randomized patients, 237 were included in the primary analysis (mean [SD] age, 56.2 [14.4] years; 104 [43.9%] women; mean [SD] baseline 25-hydroxyvitamin D level, 20.9 [9.2] ng/mL). Median (interquartile range) length of stay was not significantly different between the vitamin D3 (7.0 [4.0-10.0] days) and placebo groups (7.0 [5.0-13.0] days) (log-rank P = .59; unadjusted hazard ratio for hospital discharge, 1.07 [95% CI, 0.82-1.39]; P = .62). The difference between the vitamin D3 group and the placebo group was not significant for in-hospital mortality (7.6% vs 5.1%; difference, 2.5% [95% CI, -4.1% to 9.2%]; P = .43), admission to the intensive care unit (16.0% vs 21.2%; difference, -5.2% [95% CI, -15.1% to 4.7%]; P = .30), or need for mechanical ventilation (7.6% vs 14.4%; difference, -6.8% [95% CI, -15.1% to 1.2%]; P = .09). Mean serum levels of 25-hydroxyvitamin D significantly increased after a single dose of vitamin D3 vs placebo (44.4 ng/mL vs 19.8 ng/mL; difference, 24.1 ng/mL [95% CI, 19.5-28.7]; P < .001). There were no adverse events, but an episode of vomiting was associated with the intervention. Conclusions and Relevance: Among hospitalized patients with COVID-19, a single high dose of vitamin D3, compared with placebo, did not significantly reduce hospital length of stay. The findings do not support the use of a high dose of vitamin D3 for treatment of moderate to severe COVID-19. Trial Registration: ClinicalTrials.gov Identifier: NCT04449718.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Martineau, A. R., Jolliffe, D. A., Hooper, R. L., Greenberg, L., Aloia, J. F., Bergman, P., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Ginde, A. A., et al. (2017) · BMJ · doi:10.1136/bmj.i6583 · Cited by 2,040
Vitamin D status and ill health: a systematic review
Autier, P., Boniol, M., Pizot, C., & Mullie, P. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70165-7 · Cited by 1,107
Epidemic influenza and vitamin D
CANNELL, J. J., VIETH, R., UMHAU, J. C., HOLICK, M. F., GRANT, W. B., MADRONICH, S., GARLAND, C. F., & GIOVANNUCCI, E. (2006) · Epidemiology and Infection · doi:10.1017/s0950268806007175 · Cited by 1,034
Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts
Etten, E. V., & Mathieu, C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.06.002 · Cited by 880
The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality
Ilie, P. C., Stefanescu, S., & Smith, L. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01570-8 · Cited by 795
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
Meltzer, D. O., Best, T. J., Zhang, H., Vokes, T., Arora, V., & Solway, J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19722 · Cited by 510
Sabetta, J. R., DePetrillo, P., Cipriani, R. J., Smardin, J., Burns, L. A., & Landry, M. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011088 · Cited by 422
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels
Kaufman, H. W., Niles, J. K., Kroll, M. H., Bi, C., & Holick, M. F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239252 · Cited by 384
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19
Bilezikian, J. P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A. M., Gupta, A., Madhavan, M. V., Nair, N., Babalyan, V., Hutchings, N., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0665 · Cited by 343
Cited by
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
The health effects of vitamin D supplementation: Evidence from human studies
Bouillon, R., Manousaki, D., Rosen, C., Trajanoska, K., Rivadeneira, F., & Richards, J. B. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00593-z · Cited by 535
Consensus statement on vitamin D status assessment and supplementation: Whys, whens, and hows
Giustina, A., Bilezikian, J. P., Adler, R. A., Banfi, G., Bikle, D. D., Binkley, N. C., Bollerslev, J., Bouillon, R., Brandi, M. L., Casanueva, F. F., et al. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae009 · Cited by 392
Barnes, P. W., Robson, T. M., Neale, P. J., Williamson, C. E., Zepp, R. G., Madronich, S., Wilson, S. R., Andrady, A. L., Heikkilä, A. M., Bernhard, G. H., et al. (2022) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-022-00176-5 · Cited by 121
Sinopoli, A., Sciurti, A., Isonne, C., Santoro, M. M., & Baccolini, V. (2024) · Nutrients · doi:10.3390/nu16091345 · Cited by 40
“Vitamin D was always administered orally in the form of cholecal-ciferol/vitamin D3 in 11 RCTs [44,46–49,52 ,54,55,58–60 ], calcifediol in 3”
BackgroundMethodInfluential
Metadata
- Authors
- Murai, I. H., Fernandes, A. L., Sales, L. P., Pinto, A. J., Goessler, K. F., Duran, C. S. C., Silva, C. B. R., Franco, A. S., Macedo, M. B., Dalmolin, H. H. H., Baggio, J., Balbi, G. G. M., Reis, B. Z., Antonangelo, L., Caparbo, V. F., Gualano, B., & Pereira, R. M. R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-03-16
- Volume
- 325
- Issue
- 11
- Pages
- 1053
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3131821293
- Cited by
- 528
- References
- 23
- FWCI
- 68.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of a Single High Dose of Vitamin D 3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2020.26848
- The paper
- Murai, I. H., Fernandes, A. L., Sales, L. P., Pinto, A. J., Goessler, K. F., Duran, C. S. C., Silva, C. B. R., Franco, A. S., Macedo, M. B., Dalmolin, H. H. H., Baggio, J., Balbi, G. G. M., Reis, B. Z., Antonangelo, L., Caparbo, V. F., Gualano, B., & Pereira, R. M. R. (2021). Effect of a Single High Dose of Vitamin D 3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.26848
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.